Vancomycin Hydrochloride

Vancomycin Hydrochloride

Cat Number
API1404939
CAS Number
1404-93-9

If you have any other questions, please contact our experts.

CAS Number
1404-93-9
EINECS
604-193-8
Storage
2-8℃
Synonyms
Vancomycin HCl; VANCOMYCIN HYDROCHLORIDE
Molecular Formula
C66H76Cl3N9O24
Molecular Weight
1485.7
Smiles
C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl
Appearance
Colorless to faint yellow or tan powder
Melting Point
>190℃
General Description
Vancomycin Hydrochloride is a glycopeptide antibiotic of the tricyclic glycosylated peptide class. It exerts potent bactericidal activity against Gram-positive organisms through a mechanism distinct from beta-lactams and is considered a drug of last resort for resistant infections.
Mechanism of Action
Vancomycin Hydrochloride binds with high affinity to the D-alanyl-D-alanine terminus of peptidoglycan precursors, inhibiting transglycosylation and transpeptidation essential for bacterial cell wall cross-linking, leading to osmotic lysis of susceptible Gram-positive bacteria.
Application
Used in the treatment of serious Gram-positive infections. Vancomycin Hydrochloride is indicated for methicillin-resistant Staphylococcus aureus infections, including septicemia, infective endocarditis, osteomyelitis, pneumonia, and skin and soft tissue infections.

Vancomycin hydrochloride is a glycopeptide antibiotic that exerts its bactericidal activity through a specific and high-affinity interaction with the bacterial cell wall precursor. The primary mechanism involves the formation of a complex network of hydrogen bonds and hydrophobic interactions with the D-Ala-D-Ala terminus of the Lipid II molecule, which is a key component in the synthesis of the bacterial cell wall. This binding effectively prevents the cross-linking of peptidoglycan strands by blocking the action of essential enzymes, such as transglycosylases and transpeptidases. As a result, the bacteria are unable to synthesize a complete and functional cell wall, which compromises their structural integrity. This disruption makes the cells susceptible to osmotic pressure, ultimately leading to cell lysis and death. While inhibition of cell wall synthesis is the primary action, some studies suggest that vancomycin may also have secondary effects on bacterial RNA synthesis.

Fig. 1 Mechanism of vancomycin action. (Tabarzad M.; <i>et al</i>. 2025) Fig. 1 Mechanism of vancomycin action. (Tabarzad M.; et al. 2025)

References

  1. Tabarzad M, et al. Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems. Iranian Journal of Pharmaceutical Research: IJPR, 2025, 24(1): e160885.

Vancomycin hydrochloride was successfully formulated into polymeric microarray patches for transdermal delivery, overcoming the poor oral bioavailability of this peptide antibiotic. Two types of patches were developed: dissolving microarray patches and hydrogel-forming microarray patches. Both systems achieved significant transdermal permeation in ex vivo studies using neonatal porcine skin. In vivo pharmacokinetic studies in rats demonstrated that hydrogel-forming microarray patches achieved an area under the plasma concentration-time curve of 162.04 μg·h/mL, significantly higher than oral administration controls. This work demonstrated that transdermal delivery of vancomycin hydrochloride via microarray patches is feasible and could provide an effective alternative to intravenous administration for treating MRSA infections, particularly for skin and soft tissue infections.

Fig. 2 Preparation and characterization of Vancomycin hydrochloride-based polymeric microarray patches. (Ramadon D.; <i>et al</i>. 2020) Fig. 2 Preparation and characterization of Vancomycin hydrochloride-based polymeric microarray patches. (Ramadon D.; et al. 2020)

References

  1. Ramadon D, et al. Development, evaluation, and pharmacokinetic assessment of polymeric microarray patches for transdermal delivery of vancomycin hydrochloride. Molecular Pharmaceutics, 2020, 17(9): 3353-3368.

What therapeutic advantage does Vancomycin Hydrochloride offer over beta-lactam antibiotics?

Vancomycin Hydrochloride acts through a distinct D-Ala-D-Ala binding mechanism rather than targeting penicillin-binding proteins, making it effective against beta-lactam-resistant organisms including MRSA.

What storage conditions are required?

Store at 2-8℃ in a tightly sealed container, protected from light and moisture.

What purity grade is available?

It is supplied as a high-purity grade suitable for R&D and pharmaceutical manufacturing.

Can packaging and order quantities be customized?

Yes, both packaging formats and order quantities can be tailored to meet specific R&D and production needs.
You Might Also Like
Mizolastine
Mizolastine

Cat NO.: API108612459
CAS NO.: 108612-45-9

View Details
Florilglutamic acid (18F)
Florilglutamic acid (18F)

Cat NO.: API1196963742
CAS NO.: 1196963-74-2

View Details
Nitisinone-13C6
Nitisinone-13C6

Cat NO.: API1246815633
CAS NO.: 1246815-63-3

View Details
Linezolid-d3
Linezolid-d3

Cat NO.: API1127120380
CAS NO.: 1127120-38-0

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top